Interaction of baicalin and baicalein with antibiotics in the gastrointestinal tract
Authors:
- 1 June 2005
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 57 (6) , 743-750
Abstract
To clarify the absorption mechanism of baicalin and to investigate the interaction between baicalin and antibiotics, the pharmacokinetics of baicalin and its aglycone baicalein in normal rats and in antibiotic-treated (with a mixture of neomycin and streptomycin) rats were investigated. A method of liquid chromatography-tandem mass spectrometry with a selected reaction monitoring mode was used to determine the plasma concentrations of baicalin and baicalein. The plasma concentration of total baicalein was determined after treatment of β-glucuronidase/sulfatase. Unpaired Student's t-test was used for statistical comparison. After oral administration of baicalin, the absolute bioavailability of baicalin, based on the AUC of the baicalin parent form, was 2.2 ± 0.2% in normal rats, which decreased to 1.5 ± 0.2% in antibiotic-treated rats. Based on the AUC of total baicalein after enzymatic hydrolysis, the absorption of baicalin was 28.0 ± 5.7%, which significantly decreased to 7.7 ± 1.2% in antibiotic-treated rats. After oral administration of baicalein, the glucuronides/sulfates of baicalein were predominant in plasma. Based on the AUC of total baicalein after enzymatic hydrolysis, the absorption of baicalein was 36.1 ± 4.4% in normal rats, which did not differ markedly from that in antibiotic-treated rats (P > 0.05). The presence of baicalin isomer in plasma after oral administration of baicalin indicated that baicalin was transformed, at least in part, to baicalein before absorption, then to its conjugated metabolites in rats. Aminoglycosides decreased the absorption of baicalin, but not of baicalein, which indicated that antibiotics decreased the decomposition of baicalin to baicalein by inhibiting intestinal flora, and further influenced the absorption, metabolism and efficacy of baicalin. These interactions should be paid attention to in clinical studies when baicalin is administered in combination with antibiotics.Keywords
This publication has 12 references indexed in Scilit:
- Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytesEuropean Journal of Pharmacology, 2003
- Comparison of metabolic pharmacokinetics of baicalin and baicalein in ratsJournal of Pharmacy and Pharmacology, 2003
- Combination Use of Kampo-Medicines and Drugs Affecting Intestinal Bacterial FloraYAKUGAKU ZASSHI, 2002
- Variability of oral bioavailability for low dose methotrexate in ratsEuropean Journal of Drug Metabolism and Pharmacokinetics, 2001
- Inhibitory Effect of Baicalein, a Flavonoid in Scutellaria Root, on Eotaxin Production by Human Dermal FibroblastsPlanta Medica, 2001
- Balicalin, the Predominant Flavone Glucuronide of Scutellariae Radix, is Absorbed from the Rat Gastrointestinal Tract as the Aglycone and Restored to its Original FormJournal of Pharmacy and Pharmacology, 2000
- Reductive Metabolism of Stilbene Oxide and Styrene Oxide to the Olefins in Rats.Biological and Pharmaceutical Bulletin, 2000
- Inhibition of methylprednisolone elimination in the presence of clarithromycin therapyJournal of Allergy and Clinical Immunology, 1999
- Metabolism of the anticancer drug flavopiridol, a new inhibitor of cyclin dependent kinases, in rat liverLife Sciences, 1998
- Intestinal bacterial hydrolysis is indispensable to absorption of 18β-glycyrrhetic acid after oral administration of glycyrrhizin in ratsJournal of Pharmacy and Pharmacology, 1994